Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06939569
What this trial is testing

An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Inflammatory Bowel Disease (IBD)Metabolic Dysfunction Associated Fatty Liver Disease
Shanghai East Hospital 337
Not applicableUnknownNCT05257200
What this trial is testing

Gut Permeability and Bariatric-metabolic Surgery

Who this might be right for
NASH - Nonalcoholic SteatohepatitisBariatric Surgery CandidateIntestinal Permeability
Medical University of Vienna 125
Very early researchStudy completedNCT01940263
What this trial is testing

Purified Anthocyanin and Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Shaoguan University 63
Testing effectiveness (Phase 2)Study completedNCT03449446
What this trial is testing

Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 395
Not applicableLooking for participantsNCT02422238
What this trial is testing

Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Maastricht University Medical Center 500
Large-scale testing (Phase 3)Ended earlyNCT03053050
What this trial is testing

Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 808
Not applicableNot Yet RecruitingNCT06932289
What this trial is testing

Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions

Who this might be right for
NAFLD (Nonalcoholic Fatty Liver Disease)
VA Greater Los Angeles Healthcare System 54
Not applicableUnknownNCT02764047
What this trial is testing

Probiotics in the Treatment of NAFLD

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisFatty Liver, Nonalcoholic+1 more
Federal University of Health Science of Porto Alegre 58
Testing effectiveness (Phase 2)Looking for participantsNCT07238985
What this trial is testing

Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver
Tanta University 50
Testing effectiveness (Phase 2)Study completedNCT06342947
What this trial is testing

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

Who this might be right for
NASHMASHMetabolic Dysfunction-Associated Steatohepatitis+1 more
Aligos Therapeutics 102
Testing effectiveness (Phase 2)Study completedNCT00323414
What this trial is testing

Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver

Who this might be right for
Fatty Liver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 37
Not applicableNot Yet RecruitingNCT07336563
What this trial is testing

ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH)Metabolic SyndromeObesity & Overweight+2 more
Jarosław Drobnik 10,000
Not applicableStudy completedNCT03986684
What this trial is testing

Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverMetabolic Syndrome
Hippocration General Hospital 32
Not applicableStudy completedNCT01061684
What this trial is testing

NAFLD Pediatric Database 2

Who this might be right for
Liver Disease
Johns Hopkins Bloomberg School of Public Health 969
Early research (Phase 1)Study completedNCT05441904
What this trial is testing

Study to Assess the Safety, Tolerability, and Pharmacokinetics of PXL770 in Healthy Subjects.

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Poxel SA 16
Not applicableStudy completedNCT06195943
What this trial is testing

Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
NASH - Nonalcoholic SteatohepatitisNASHExercise+1 more
Milton S. Hershey Medical Center 17
Not applicableLooking for participantsNCT07321925
What this trial is testing

Thermoacoustic Method for Estimating Liver Fat Fraction

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Fatty Liver Disease, Nonalcoholic
Endra Lifesciences 49
Post-approval studies (Phase 4)Study completedNCT02210715
What this trial is testing

Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected Patients

Who this might be right for
HIVFatty LiverNonalcoholic Steatohepatitis
McGill University Health Centre/Research Institute of the McGill University Health Centre 31
Not applicableStudy completedNCT03590626
What this trial is testing

Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver DiseaseType2 Diabetes Mellitus
Medanta, The Medicity, India 60
Large-scale testing (Phase 3)UnknownNCT05605158
What this trial is testing

Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
Tanta University 56
Next Page